Financial insights of ELTX

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Research and development	6,757	6,835*	5,039	7,006
General and administrative	3,845	3,675*	3,006	3,085
Total operating expenses	10,602	10,509	8,045	10,091
Loss from operations	-10,602	-10,509*	-8,045	-10,091
Grant income	-	-207*	0	415
Change in fair value of warrant liabilities	984	-2,090*	1,811	859
Loss on issuance of pre-funded warrants	-	0*	0	0
Gain on sale of equipment	-	0*	0	0
Foreign exchange transaction gain	13	0*	0	0
Interest income	157	226*	199	168
Interest expense	407	203*	426	194
Total other expense, net	-1,221	1,905*	-2,038	-470
Us federal statutory income tax rate	-	-2,077*	-	-
Domestic state and local taxes, net of federal effect	-	0*	-	-
Foreign tax effects	-	5*	-	-
Research and development credits	-	282*	-	-
Nondeductible stock based compensation	-	78*	-	-
Change in fair value of warrants	-	101*	-	-
Other nontaxable and nondeductible items	-	61*	-	-
Changes in valuation allowance	-	2,115*	-	-
Provision for income taxes	-	0*	-	-
Net loss	-11,823	-8,604*	-10,083	-10,561
Foreign currency translation adjustment	5	-121*	39	74
Comprehensive loss	-11,818	-8,726	-10,044	-10,487

Basic EPS	-0.65	-0.662	-0.6	-0.66
Diluted EPS	-0.65	-0.662	-0.6	-0.66
Basic Average Shares	18,211,745	13,186,354	16,692,476	16,059,423
Diluted Average Shares	18,211,745	13,186,354	16,692,476	16,059,423

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.